Sharjah24 – Reuters: Britain has approved the COVID-19 vaccine developed by Novavax for use in those aged 18 and older, the country's medicines regulator said on Thursday, bringing a fifth coronavirus vaccine to its roster.
The vaccine, Nuvaxovid, was approved as a first and second dose after meeting the required safety, quality and effectiveness standards, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) said https://www.gov.uk/government/news/novavax-covid-19-vaccine-nuvaxovid-approved-by-mhra in a statement.
The British approval for Nuvaxovid comes days after the drugmaker filed for U.S. authorization https://www.reuters.com/world/us/novavax-files-us-authorization-covid-19-vaccine-2022-01-31 of the vaccine following months of struggles with development and manufacturing problems.
"We are continuing our vital safety work in monitoring the use of all COVID-19 vaccines, to ensure that their benefits in protecting people against COVID-19 disease continue to outweigh any risks," MHRA Chief Executive June Raine said.
For an optimal experience, please
